Spyre Therapeutics Stock (SYRE)
Track Spyre Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
SYRE
Spyre Therapeutics
healthcare
$71.88
▲ +57.52 (+383.72%) past year
Market Cap
$6.40B
P/E Ratio
—
1Y Return
+383.72%
EPS (TTM)
-$2.36
Read the latest TheStreet Pro articles mentioning Spyre Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning SYRE yet.
Daily Diary Mentions
0 mentionsNo diary mentions for SYRE yet.